Invest now
Saroja Pharma Industries India share price
- ₹29.95(0.00%)July 14, 2026 15:40:00 PM IST
- NSE
- BSE
- Vol : 0 (NSE + BSE)Last 20 day avg : 4.24 K
Saroja Pharma Industries India is trading 0.00% upper at Rs 29.95 as compared to its last closing price. Saroja Pharma Industries India has been trading in the price range of 0.00 & 0.00. Saroja Pharma Industries India has given -25.13% in this year & -4.47% in the last 5 days. Saroja Pharma Industries India has TTM P/E ratio 6.97 as compared to the sector P/E of 31.93.The company posted a net profit of 1.05 Crores in its last quarter.Listed peers of Saroja Pharma Industries India include Sun Pharmaceutical Industries (-0.06%), Divi's Laboratories (0.48%), Torrent Pharmaceuticals (-0.30%).The Mutual Fund holding in Saroja Pharma Industries India was at -% in . The MF holding has - from the last quarter. The FII holding in Saroja Pharma Industries India was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 16 Jul 2026, 07:47 PM IST
- Debt To EquityHigher than industry0.83The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation0.49The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Saroja Pharma Industries India Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,951.30 | -0.06 | 4,68,171.21 | 38.45 | 5.56 | 0.83 | 0.47 |
| Divi's Laboratories | 7,319.75 | 0.48 | 1,94,316.36 | 69.15 | 10.83 | 0.44 | 0.03 |
| Torrent Pharmaceuticals | 5,002.75 | -0.30 | 1,69,368.61 | 74.85 | 19.78 | 0.78 | 141.16 |
| Cipla | 1,428.00 | -0.69 | 1,15,360.31 | 27.97 | 3.38 | 0.90 | 1.11 |
| Zydus Lifesciences | 1,155.90 | 0.13 | 1,15,204.94 | 21.90 | 4.27 | 0.09 | 14.22 |
Mutual Fund Ownership
View allSaroja Pharma Industries India Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-30 | Audited Results |
| 2025-11-13 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-05-29 | Audited Results |
About the company Saroja Pharma Industries India
- IndustryBiotechnology & Drugs
- ISININE0PCL01011
- BSE Code
- NSE CodeSAROJA
Saroja Pharma Industries India Limited is an India-based company. The Company operates as a trader, exporter and supplier of specialty chemicals. It offers pharma active pharmaceutical ingredient (API) products which include Closantel Sodium Dihydrate, Furosemide, Oxfendazole, Rafoxanide, Trichlorocarbanilide (TCC), Clorsulon, Diethyl Carbamazine, Niclosamide, Pyrantel Pamoate, and Povidone lodine. It also offers pharma intermediates which include Intermediates for Amoxapine & Loxapine, Methyl-3-Amino-2-Thiophene Carboxy, Intermediates for Tiotropium Bromide, Intermediates for Suxamethonium, Intermediates for Brinzolamide, Intermediates for Lornoxicam, Intermediates for Linezolid, Intermediates for Glimepiride, Intermediates for Gefitinib, and Intermediates for Ezetimibe. It also offers Aluminium Chloride Anhydrous Powder, Triethylamine Hydrochloride, Potassium Carbonate Granules, Sodium Hydro Sulphide, Tetra Butyl Ammonium Bromide, and Chlorosulphonic Acid.
Saroja Pharma Industries India Share Price FAQs
Saroja Pharma Industries India is trading at 29.95 as on Tue Jul 14 2026 10:10:00. This is 0.00% upper as compared to its previous closing price of 29.95.
The market capitalization of Saroja Pharma Industries India is 12.04 Cr as on Tue Jul 14 2026 10:10:00.
The 52 wk high for Saroja Pharma Industries India is 60.00 whereas the 52 wk low is 28.00
Saroja Pharma Industries India can be analyzed on the following key metrics -
- TTM P/E: 6.97
- Sector P/E: 31.93
- Dividend Yield: 0.00%
- D/E ratio: 0.83
Saroja Pharma Industries India reported a net profit of 1.62 Cr in 2026.
Quick Links
EQUITY QUICK LINKS
Saroja Pharma Industries India QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.